PALO ALTO, Calif., Jan. 8, 2020 /PRNewswire/ -- Kodiak Sciences Inc.
(Nasdaq: KOD), a clinical stage biopharmaceutical company
specializing in novel therapeutics to treat chronic,
high-prevalence retinal diseases, announced today that management
will present a company overview at the J.P. Morgan Healthcare
Conference in San Francisco,
California, on Tuesday, January 14,
2020 at 7:30 a.m. Pacific Time
(10:30 a.m. Eastern Time).
A live audio webcast of the presentation will be available on
the "Investors & Media" section of Kodiak's website at
http://ir.kodiak.com/ and will remain available for replay for
a limited time following the event.
About Kodiak Sciences Inc.
Kodiak (Nasdaq: KOD) is a clinical stage biopharmaceutical
company specializing in novel therapeutics to treat chronic,
high-prevalence retinal diseases. Founded in 2009, we are focused
on bringing new science to the design and manufacture of next
generation retinal medicines to prevent and treat the leading
causes of blindness globally. Our ABC Platform™ merges the fields
of antibody-based and chemistry-based therapies and is at the core
of Kodiak's discovery engine. Kodiak's lead product candidate,
KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being
developed for the treatment of retinal vascular diseases including
age-related macular degeneration and diabetic eye diseases. Kodiak
has leveraged its ABC Platform to build a pipeline of product
candidates in various stages of development including KSI-501, our
bispecific anti-IL-6/VEGF biopolymer conjugate for the treatment of
neovascular retinal diseases with an inflammatory component, and we
are expanding our early research pipeline to include ABC Platform
based triplet inhibitors for multifactorial retinal diseases such
as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA. For more information, please
visit www.kodiak.com.
"Kodiak," "ABC Platform" and the Kodiak logo are registered
trademarks or trademarks of Kodiak Sciences Inc. in various
jurisdictions.
View original
content:http://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-38th-annual-jp-morgan-healthcare-conference-300983191.html
SOURCE Kodiak Sciences Inc.